Abstract
Original language | English |
---|---|
Article number | CD015318 |
Journal | Cochrane Database of Systematic Reviews |
Volume | 2023 |
Issue number | 6 |
DOIs | |
Publication status | Published - 29 Jun 2023 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Cochrane Database of Systematic Reviews, Vol. 2023, No. 6, CD015318, 29.06.2023.
Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Prognostic accuracy of imaging findings for predicting morbidity and mortality in patients with COVID-19
AU - Islam, Nayaar
AU - Kashif Al-Ghita, Mohammed
AU - Ebrahimzadeh, Sanam
AU - Dawit, Haben
AU - Prager, Ross
AU - Alvarez, Gonzalo G.
AU - Cohen, J. rémie F.
AU - Korevaar, Daniël A.
AU - Deeks, Jonathan J.
AU - Verbakel, Jan Y.
AU - Damen, Johanna A. AG
AU - Ochodo, Eleanor A.
AU - Venugopalan Nair, Anirudh
AU - Dinnes, Jacqueline
AU - Dennie, Carole
AU - van den Bruel, Ann
AU - van de Wijgert, Janneke
AU - Sikora, Lindsey
AU - Spijker, René
AU - Hare, Samanjit S.
AU - McInnes, Matthew D. F.
N1 - Funding Information: The editorial base of the Cochrane Infectious Diseases Group is funded by UK aid from the UK government for the benefit of low- and middle-income countries (project number 300342-104). The views expressed do not necessarily reflect the UK government’s official policies. Jonathan Deeks is a United Kingdom National Institute for Health Research (NIHR) Senior Investigator Emeritus. Jonathan Deeks and Jacqueline Dinnes are supported by the NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. The search strategy was reviewed by Sarah Visintini and Peter Farrell (Research Librarians, University of Ottawa). The following people conducted the editorial process for this article. Sign-off Editor (final editorial decision): Michael Brown, Michigan State University College of Human Medicine Managing Editor (selected peer reviewers, collated peer-reviewer comments, provided editorial guidance to authors, edited the article): Anne-Marie Stephani, Cochrane Central Editorial Service Editorial Assistant (conducted editorial policy checks and supported editorial team): Lisa Wydrzynski, Cochrane Central Editorial Service Copy Editor (copy-editing and production): Julia Turner, Cochrane Central Production Service Peer-reviewers (provided comments and recommended an editorial decision): Ali Gholamrezanezhad, Keck School of Medicine, University of Southern California (clinical/content review); Jaber S Alqahtani, Department of Respiratory Care, Prince Sultan Military College of Health Sciences, Dammam, Saudi Arabia (clinical/content review); Paul Garner, Cochrane Infectious Diseases Group (clinical/content review); Debra Knauft (consumer review); Robert Wolff, Kleijnen Systematic Reviews Ltd, UK (methods review); Rachel Richardson, Associate Editor, Cochrane (methods review); Maria-Inti Metzendorf, Institute of General Practice, Medical Faculty of the Heinrich Heine University, Düsseldorf, Germany (search review) Sign-off Editor (final editorial decision): Michael Brown, Michigan State University College of Human Medicine Managing Editor (selected peer reviewers, collated peer-reviewer comments, provided editorial guidance to authors, edited the article): Anne-Marie Stephani, Cochrane Central Editorial Service Editorial Assistant (conducted editorial policy checks and supported editorial team): Lisa Wydrzynski, Cochrane Central Editorial Service Copy Editor (copy-editing and production): Julia Turner, Cochrane Central Production Service Peer-reviewers (provided comments and recommended an editorial decision): Ali Gholamrezanezhad, Keck School of Medicine, University of Southern California (clinical/content review); Jaber S Alqahtani, Department of Respiratory Care, Prince Sultan Military College of Health Sciences, Dammam, Saudi Arabia (clinical/content review); Paul Garner, Cochrane Infectious Diseases Group (clinical/content review); Debra Knauft (consumer review); Robert Wolff, Kleijnen Systematic Reviews Ltd, UK (methods review); Rachel Richardson, Associate Editor, Cochrane (methods review); Maria-Inti Metzendorf, Institute of General Practice, Medical Faculty of the Heinrich Heine University, Düsseldorf, Germany (search review) Publisher Copyright: Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2023/6/29
Y1 - 2023/6/29
N2 - Objectives: This is a protocol for a Cochrane Review (prognosis). The objectives are as follows:. To evaluate the accuracy of imaging findings (on chest CT, chest X-ray, and ultrasound of the lungs) to predict the following medical outcomes in people with COVID-19. Morbidity, including: complications (e.g. development of hypoxia, severe AKI, delirium); escalation of care (e.g. hospital admission, ICU admission, non-invasive ventilation, intubation, mechanical ventilation, ECMO, need for renal replacement therapy, need for transfusion); and length of hospital admission. Mortality, including disease-specific mortality; and all-cause mortality. We will evaluate each outcome separately (e.g. hypoxia alone), or in combinations (e.g. hypoxia and AKI), depending on the granularity of the outcome data reported in primary studies. We will evaluate each outcome according to time horizon, as detailed in the Methods section. Secondary objectives When data are available, we will investigate whether prognostic accuracy varies according to covariates of interest, including imaging technique, timing of imaging test, test used to confirm COVID-19, duration of symptoms, timing of outcome confirmation, study design, study setting, participant age, and presence or absence of pulmonary embolism (PE) on CT pulmonary angiography (CTPA).
AB - Objectives: This is a protocol for a Cochrane Review (prognosis). The objectives are as follows:. To evaluate the accuracy of imaging findings (on chest CT, chest X-ray, and ultrasound of the lungs) to predict the following medical outcomes in people with COVID-19. Morbidity, including: complications (e.g. development of hypoxia, severe AKI, delirium); escalation of care (e.g. hospital admission, ICU admission, non-invasive ventilation, intubation, mechanical ventilation, ECMO, need for renal replacement therapy, need for transfusion); and length of hospital admission. Mortality, including disease-specific mortality; and all-cause mortality. We will evaluate each outcome separately (e.g. hypoxia alone), or in combinations (e.g. hypoxia and AKI), depending on the granularity of the outcome data reported in primary studies. We will evaluate each outcome according to time horizon, as detailed in the Methods section. Secondary objectives When data are available, we will investigate whether prognostic accuracy varies according to covariates of interest, including imaging technique, timing of imaging test, test used to confirm COVID-19, duration of symptoms, timing of outcome confirmation, study design, study setting, participant age, and presence or absence of pulmonary embolism (PE) on CT pulmonary angiography (CTPA).
UR - http://www.scopus.com/inward/record.url?scp=85164186598&partnerID=8YFLogxK
U2 - https://doi.org/10.1002/14651858.CD015318
DO - https://doi.org/10.1002/14651858.CD015318
M3 - Article
SN - 1465-1858
VL - 2023
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 6
M1 - CD015318
ER -